Skip to Content

'
Chelsea Pinnix, MD, PhD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Upon completion of the combined degree program at the University of Pennsylvania, I embarked on residency training in Radiation Oncology at the University of Texas MD Anderson Cancer Center.  Being at MD Anderson was the logical progression in my professional research and clinical development given that it encourages research at the post-doctoral level while offering the insight that can only be gleaned through clinical interactions. Radiation oncology is an ever evolving specialty. The unanswered questions continue to compound.  Clinical scientists continue to observe superior survival of patients treated with combined chemotherapy and radiation approaches, yet the mechanisms behind this synergistic therapeutic approach are not fully understood.  The pursuit of technical advancement continues as investigators seek novel ways to improve patient outcomes.  Moreover, radiobiologists also have intense interest in identifying approaches to minimize treatment related side effects.  As multi-modality approaches to cancer continue to improve patient outcomes, limiting treatment related morbidity is essential.  This is especially true in the treatment of young patients with radiation therapy.

I joined the faculty in the division of Radiation Oncology at MD Anderson Cancer Center in July of 2012.  My clinical and research interests lie in improving the outcomes of patients with lymphoma.  My ultimate aspiration is to advance the clinical outcomes of patients afflicted with Hodgkin’s and Non-Hodgkin’s Lymphoma via the minimization of normal tissue toxicity related to radiotherapy. Another interest lies in the identification of improved treatment strategies that incorporate radiation in the management of aggressive and refractory lymphomas. I intend to contribute to the growing body of literature in the field of radiation oncology with the ultimate goal of influencing the standard of care as well as the prevention and management of long term treatment related toxicity.

Education & Training

Degree-Granting Education

2007 University of Pennsylvania, Philadelphia, PA, MD, Medicine
2007 University of Pennsylvania, Philadelphia, PA, PhD, Cell and Molecular Biology
1999 University of Maryland Baltimore County, Baltimore, MD, BS, Magna Cum Laude, Biochemistry

Postgraduate Training

7/2008-6/2012 Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
7/2007-6/2008 Clinical Internship, Internal Medicine, Johns Hopkins University, Sinai Hospital, Baltimore, MD

Experience/Service

Other Appointments/Responsibilities

Clinical Site Liaison- Hematologic Malignancies, MD Anderson Regional Care Center- Cooper, New Jersey, NJ, 9/2015-present
Member, Alliance of Dedicated Cancer Centers (ADCC) Secondary Pathology Review Project, Chicago, IL, 5/2015-present
Ambulatory Specialty Content Validation Radiation Oncology-Liaison, MD Anderson EPIC Implementation Working Group, Houston, TX, 4/2015-present
Hematologic Malignancies Radiation Oncology Liaison, MD Anderson Radiation Oncology Brocade (Rad Onc Epic Module), Houston, TX, 2/2015-present
Clinical Site Liaison- Hematologic Malignancies, MD Anderson Regional Care Center- Bay Area, Houston, TX, 9/2014-present
Clinical Site Liaison- Hematologic Malignancies, MD Anderson Regional Care Center- Katy, Houston, TX, 9/2014-present
Clinical Site Liaison- Hematologic Malignancies, MD Anderson Regional Care Center- Sugarland, Houston, TX, 9/2014-present
Clinical Site Liaison- Hematologic Malignancies, MD Anderson Regional Care Center- Woodlands, Houston, TX, 9/2014-present
Clinical Site Liaison- Hematologic Malignancies, MD Anderson Regional Care Center- Albuquerque, Albuquerque, NM, 9/2014-present

Institutional Committee Activities

Member, Division of Radiation Oncology, Palliative Therapy Quality Assurance Task Group, 9/2015-present
Committee Member, ACGME Core Faculty for Residency, 8/2015-present
Radiation Oncology Representative, Division Council on Gender Inclusiveness, 7/2015-present
Committee Member, Division of Radiation Oncology, Grand Rounds Planning Committee, 6/2015-present
Chair of the Divisional Awards Committee, Division of Radiation Oncology, 4/2015-present
Faculty Senate, Radiation Oncology Representative, 9/2014-present
Team Co-Lead, Primary Mediastinal Large B Cell Lymphoma Treatment Algorithm Core Development, 2013-present

Honors and Awards

2012 Trainee Excellence Award, The University of Texas MD Anderson Cancer Center
2010-2012 Postdoctoral Science Research Fellowship Grant, United Negro College Fund-Merck

Professional Memberships

American Association for Women Radiologists
Treasurer, 2014-2015
Member, 2010-present
American College of Radiology
Member, 2012-present
American Society of Clinical Oncology
Member, 2014-present
American Society of Radiation Oncology
Member, 2008-present
ASTRO CME/MOC Committee, VA
Committee Member, 4/2015-present
International Lymphoma Radiation Oncology Group (ILROG), New York, NY
Council Member, 4/2015-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Pinnix CC, Osborne EM, Chihara D, Lai P, Zhou S, Ramirez MM, Oki Y, Hagemeister FB, Rodriguez AM, Samaniego F, Fowler N, Romaguera JE, Turturro F, Fayad L, Westin JR, Nastoupil L, Neelapu SS, Cheah CY, Dabaja BS, Milgrom SA, Smith GL, Horace P, Milbourne A, Wogan CF, Ballas L, Fanale MA. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy. JAMA Oncol 2(8):1065-9, 8/2016. e-Pub 5/2016. PMID: 27227654.
2. Cheah CY, Bröckelmann PJ, Chihara D, Moskowitz A, Engert A, Jerkeman M, El-Galaly TC, Augustson B, Vose J, Bartlett NL, Villa D, Connors JM, Feldman T, Pinnix CC, Milgrom SA, Dabaja B, Oki Y, Fanale MA. Clinical characteristics and outcomes of patients with hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration. Am J Hematol. e-Pub 5/2016. PMID: 27222367.
3. Nieto Y, Valdez BC, Thall PF, Jones RB, Wei W, Myers A, Hosing C, Ahmed S, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Shah N, Bashir Q, Alousi A, Oki Y, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma. Cancer. e-Pub 5/2016. PMID: 27203405.
4. Milgrom SA, Cheah CY, Pinnix CC, Smith GL, Dabaja BS, Horace P, Chevez-Barrios P, Fowler NH, Gombos DS. Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma. Leuk Lymphoma. e-Pub 4/2016. PMID: 27075636.
5. Cheah CY, Milgrom S, Chihara D, Gombos DS, Pinnix CC, Dabaja BS, Fowler NH. Intensive chemoimmunotherapy and bilateral globe irradiation as initial therapy for primary intraocular lymphoma. Neuro Oncol 18(4):575-81, 4/2016. e-Pub 10/2015. PMCID: PMC4799685.
6. Gunther JR, Fanale MA, Reddy JP, Akhtari M, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Allen PK, Osborne EM, Mawlawi O, Dabaja BS. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. Int J Radiat Oncol Biol Phys. e-Pub 4/2016. PMID: 27325479.
7. Pinnix CC, Shah JJ, Chuang H, Costelloe CM, Medeiros LJ, Wogan CF, Reed V, Smith GL, Milgrom S, Patel K, Huo J, Turturro F, Romaguera J, Fayad L, Oki Y, Fanale MA, Westin J, Nastoupil L, Hagemeister FB, Rodriguez A, Qazilbash M, Shah N, Bashir Q, Ahmed S, Nieto Y, Hosing C, Rohren E, Dabaja B. Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. Clin Lymphoma Myeloma Leuk 16(3):122-8, 3/2016. e-Pub 12/2015. PMID: 26795083.
8. Moore JA, Moore MB, Samaniego F, Pinnix CC, Moore DF. Small lymphocytic lymphoma presenting with hypopituitarism. Am J Med 129(1):e9-e10, 1/2016. e-Pub 9/2015. PMID: 26344628.
9. Milgrom SA, Nieto Y, Pinnix CC, Smith GL, Wogan CF, Rondon G, Medeiros LJ, Kebriaei P, Dabaja BS. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports. J Med Case Rep 10:209, 2016. e-Pub 7/2016. PMCID: PMC4964004.
10. Akhtari M, Reddy JP, Pinnix CC, Allen PK, Osborne EM, Gunther JR, Milgrom SA, Smith GL, Wogan CF, Fowler N, Rodriguez MA, Dabaja B. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 57(1):1-5, 2016. e-Pub 5/2015. PMID: 25860237.
11. Hosing C, Bassett R, Dabaja B, Talpur R, Alousi A, Ciurea S, Popat U, Qazilbash M, Shpall EJ, Oki Y, Nieto Y, Pinnix C, Fanale M, Maadani F, Donato M, Champlin R, Duvic M. Allogeneic Stem Cell Transplantation in Patients With Cutaneous Lymphoma: Updated Results From a Single Institution. Ann Oncol 26(12):2490-5, 12/2015. e-Pub 9/2015. PMCID: PMC4855245.
12. Reddy JP, Akhtari M, Smith GL, Pinnix C, Osborne EM, Gunther JR, Allen PK, Yehia ZA, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja BS. Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease. Clin Lymphoma Myeloma Leuk 15(11):664-670.e2, 11/2015. e-Pub 8/5/2015. PMID: 26321471.
13. Nieto Y, Valdez BC, Thall PF, Ahmed S, Jones RB, Hosing C, Popat U, Shpall EJ, Qazilbash M, Gulbis A, Anderlini P, Alousi A, Shah N, Bashir Q, Liu Y, Oki Y, Hagemeister F, Fanale M, Dabaja B, Pinnix C, Champlin R, Andersson BS. Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas. Biol Blood Marrow Transplant 21(11):1914-20, 11/2015. e-Pub 6/2015. PMCID: PMC4781754.
14. Zhou R, Yang J, Pan T, Milgrom S, Pinnix CC, Shi A, Yang J, Liu Y, Nguyen Q, Gomez D, Dabaja B, Balter P, Court L, Liao Z. SU-E-J-129: Atlas Development for Cardiac Automatic Contouring Using Multi-Atlas Segmentation. Med Phys 42(6):3294, 6/2015. PMID: 26127520.
15. Tao R, Allen PK, Rodriguez A, Shihadeh F, Pinnix CC, Arzu I, Reed VK, Oki Y, Westin JR, Fayad LE, Medeiros LJ, Dabaja B. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma. Int J Radiat Oncol Biol Phys 92(1):122-9, 5/2015. e-Pub 3/2015. PMID: 25754633.
16. Pinnix CC, Smith GL, Milgrom S, Osborne EM, Reddy JP, Akhtari M, Reed V, Arzu I, Allen PK, Wogan CF, Fanale MA, Oki Y, Turturro F, Romaguera J, Fayad L, Fowler N, Westin J, Nastoupil L, Hagemeister FB, Rodriguez MA, Ahmed S, Nieto Y, Dabaja B. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 92(1):175-82, 5/2015. PMCID: PMC4418193.
17. Pinnix CC, Dabaja B, Ahmed MA, Chuang HH, Costelloe C, Wogan CF, Reed V, Romaguera JE, Neelapu S, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Nastoupil L, Turturro F, Fowler N, Fanale MA, Nieto Y, Khouri IF, Ahmed S, Medeiros LJ, Davis RE, Westin J. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 92(1):113-21, 5/2015. PMCID: PMC4418191.
18. Cachia D, Kamiya-Matsuoka C, Pinnix CC, Chi L, Kantarjian HM, Cortes JE, Daver N, Woodman K. Myelopathy following intrathecal chemotherapy in adults: a single institution experience. J Neurooncol 122(2):391-8, 4/2015. e-Pub 2/2015. PMCID: PMC4369460.
19. Youssef B, Shank J, Reddy JP, Pinnix CC, Farha G, Akhtari M, Allen PK, Fanale MA, Garcia JA, Horace PH, Milgrom S, Smith GL, Nieto Y, Arzu I, Wang H, Fowler N, Rodriguez MA, Dabaja B. Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma. Radiat Oncol 10(1):206, 2015. e-Pub 9/2015. PMCID: PMC4582821.
20. Yusuf SW, Howell RM, Gomez D, Pinnix CC, Iliescu CA, Banchs J. Radiation-related heart and vascular disease. Future Oncol 11(14):2067-76, 2015. PMID: 26198837.
21. Walker GV, Shihadeh F, Kantarjian H, Allen P, Rondon G, Kebriaei P, O'Brien S, Kedir A, Said M, Grant JD, Thomas DA, Gidley PW, Arzu I, Pinnix C, Reed V, Dabaja BS. Comprehensive craniospinal radiation for controlling central nervous system leukemia. Int J Radiat Oncol Biol Phys 90(5):1119-25, 12/2014. PMID: 25539370.
22. Haque W, Voong KR, Shihadeh F, Arzu I, Pinnix C, Mazloom A, Medeiros LJ, Romaguera J, Rodriguez A, Wang M, Allen P, Dabaja B. Radiation therapy is an effective modality in the treatment of mantle cell lymphoma, even in heavily pretreated patients. Clin Lymphoma Myeloma Leuk 14(6):474-9, 12/2014. e-Pub 7/2014. PMID: 25108680.
23. Oki Y, Noorani M, Lin P, Davis RE, Neelapu SS, Ma L, Ahmed M, Rodriguez MA, Hagemeister FB, Fowler N, Wang M, Fanale MA, Nastoupil L, Samaniego F, Lee HJ, Dabaja BS, Pinnix CC, Medeiros LJ, Nieto Y, Khouri I, Kwak LW, Turturro F, Romaguera JE, Fayad LE, Westin JR. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. Br J Haematol 166(6):891-901, 9/2014. e-Pub 6/2014. PMID: 24943107.
24. Chi P, Pinnix C, Dabaja B, Wang C, Aristophanous, Tang S. SU-E-T-404: Simple Field Tachnique for Total Body Irrdiation in Large Patients. Medical Physics 41(6):318-318, 6/2014. PMID: 10.1118/1.4888737.
25. Aristophanous M, Chi P, Tung S, Pinnix C, Dabaja B. SU-E-T-522: A Multi-Isocenter VMAT Technique for Cranio-Spinal Irradiation. Medical Physics 41(6):347-347, 6/2014.
26. Voong KR, McSpadden K, Pinnix CC, Shihadeh F, Reed V, Salehpour MR, Arzu I, Wang H, Hodgson D, Garcia J, Aristophanous M, Dabaja BS. Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma. Radiat Oncol 9(1):94, 2014. e-Pub 4/2014. PMCID: PMC4013438.
27. Gomez DR, Poenisch F, Pinnix CC, Sheu T, Chang JY, Memon N, Mohan R, Rozner MA, Dougherty AH. Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictors. Int J Radiat Oncol Biol Phys 87(3):570-575, 11/1/2013. PMCID: PMC3931127.
28. Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 85(3):e143-e149, 3/1/2013. e-Pub 11/29/2012. PMID: 23200173.
29. Likhacheva A, Pinnix CC, Parikh NR, Allen PK, McAleer MF, Chiu MS, Sulman EP, Mahajan A, Guha-Thakurta N, Prabhu SS, Cahill DP, Luo D, Shiu AS, Brown PD, Chang EL. Predictors of survival in contemporary practice after initial radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 85(3):656-661, 3/1/2013. e-Pub 8/14/2012. PMID: 22898384.
30. Likhacheva A, Pinnix CC, Parikh N, Allen PK, Guha-Thakurta N, McAleer M, Sulman EP, Mahajan A, Shiu A, Luo D, Chiu M, Brown PD, Prabhu SS, Chang EL. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. J Neurosurg 117 Suppl:38-44, 12/2012. PMCID: PMC3910154.
31. Pinnix CC, Reed V, Dabaja B. Gastric MALT lymphoma treated with primary radiotherapy in the setting of autoimmune disease. J Natl Compr Canc Netw 10(7):815-819, 7/1/2012. PMID: 22773797.
32. Pinnix C, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Arriaga L, Munsell MF, Kelly P, Hoffman KE, Smith BD, Buchholz TA, Yu TK. Topical hyaluronic acid vs standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 83(4):1089-1094, 7/2012. e-Pub 12/2011. PMCID: PMC3935608.
33. Pinnix CC, Fontanilla HP, Hayes-Jordan A, Subbiah V, Bilton SD, Chang EL, Grosshans DR, McAleer MF, Sulman EP, Woo SY, Anderson P, Green HL, Mahajan A. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery. Int J Radiat Oncol Biol Phys 83(1):317-326, 5/1/2012. e-Pub 11/19/2011. PMCID: PMC4005898.
34. Wang X, Pan T, Pinnix C, Zhang SX, Salehpour M, Sun TL, Gladish G, Strom EA, Perkins GH, Tereffe W, Woodward W, Hoffman KE, Buchholz TA, Yu TK. Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 82(2):708-714, 2/2012. e-Pub 3/2011. PMCID: PMC4158740.
35. Fontanilla HP, Pinnix CC, Ketonen LM, Woo SY, Vats TS, Rytting ME, Wolff JE, Mahajan A. Palliative reirradiation for progressive diffuse intrinsic pontine glioma. Am J Clin Oncol 35(1):51-57, 2/2012. PMID: 21297433.
36. Wu PH, Coultrap S, Pinnix C, Davies KD, Tailor R, Ang KK, Browning MD, Grosshans DR. Radiation induces acute alterations in neuronal function. PLoS One 7(5):e37677, 2012. e-Pub 5/2012. PMCID: PMC3360766.
37. Skinner HD, Garden AS, Rosenthal DI, Ang KK, Morrison WH, Esmaeli B, Pinnix CC, Frank SJ. Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas MD Anderson Cancer Center experience. Cancer 117(12):2801-10, 6/15/2011. e-Pub 1/10/2011. PMID: 21656758.
38. Sharp HJ, Pinnix CC, Jhingran A, Euscher ED, Rohren EM, Ramirez PT. PET/CT in a patient with adenoma malignum of the uterine cervix. Clin Nucl Med 36(6):468-469, 6/2011. PMID: 21552028.
39. Pinnix CC, Lee JT, Liu ZJ, McDaid R, Balint K, Beverly LJ, Brafford PA, Xiao M, Himes B, Zabierowski SE, Yashiro-Ohtani Y, Nathanson KL, Bengston A, Pollock PM, Weeraratna AT, Nickoloff BJ, Pear WS, Capobianco AJ, Herlyn M. Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res 69(13):5312-5320, 7/1/2009. e-Pub 6/23/2009. PMCID: PMC2755513.
40. Pinnix CC, Herlyn M. The many faces of Notch signaling in skin-derived cells. Pigment Cell Res 20(6):458-465, 12/2007. PMID: 17935489.
41. Liu ZJ, Xiao M, Balint K, Soma A, Pinnix CC, Capobianco AJ, Velazquez OC, Herlyn M. Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1. FASEB J 20(7):1009-1011, 5/2006. e-Pub 3/29/2006. PMID: 16571776.
42. Liu ZJ, Xiao M, Balint K, Smalley KS, Brafford P, Qiu R, Pinnix CC, Li X, Herlyn M. Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res 66(8):4182-4190, 4/15/2006. PMID: 16618740.
43. Balint K, Xiao M, Pinnix CC, Soma A, Veres I, Juhasz I, Brown EJ, Capobianco AJ, Herlyn M, Liu ZJ. Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 115(11):3166-3176, 11/2005. e-Pub 10/20/2005. PMCID: PMC1257536.
44. Pinnix CC, Kogan M, Herlyn M. Melanoma stem cells: have we overlooked them? The Melanoma Letter 23(3):3-4, 2005.
45. De Guzman RN, Wu ZR, Stalling CC, Pappalardo L, Borer PN, Summers MF. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science 279(5349):384-388, 1/1998. PMID: 9430589.

Invited Articles

1. Pinnix CC. Radiation Therapy for Diffuse Large B-Cell Lymphoma: Indications, Outcomes, and Controversies. Int J Radiat Oncol Biol Phys 94(4):641-4, 3/2016. PMID: 26972636.

Editorials

1. Pinnix CC. Comment on: breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin’s lymphoma in England and Wales: a national cohort study. Breast Diseases, A Year Book Quarterly. In Press.
2. Pinnix CC, Buchholz TA. Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of a phase III randomized trial. Breast Diseases, A Year Book Quarterly 23(1):74-75, 2013.

Abstracts

1. Walker GV, Shihadeh F, Kantarjian H, Gidley PW, Arzu I, Pinnix CC, Reed VK, Dabaja B. Controlling central nervous system leukemia: does the extent of the radiation therapy field influence outcomes?. Proceedings of the American Society of Radiation Oncology Annual Meeting. In Press.
2. Dabaja B, Wang H, Voong RK, Pinnix CC, Shihadeh F, Reed VK, Salehpour M, Arzu I, Garcia J. Image guided radiation therapy proves its benefit in detecting the daily unpredictable shape change of the stomach, a study of patients treated for stomach lymphoma. Proceedings of the American Society of Radiation Oncology Annual Meeting. In Press.
3. Dabaja B, Voong RK, McSpadden K, Pinnix CC, Shihadeh F, Reed VK, Salehpour M, Arzu I, Wang H, Garcia J. Intensity modulated radiation therapy (IMRT) using butterfly technique offers a dosimetric advantage to critical organs in young female patients with mediastinal Hodgkin’s lymphoma. Proceedings of the American Society of Radiation Oncology Annual Meeting. In Press.
4. Pinnix CC, Perrin K, Reed VK, Dabaja B. Intensity modulated radiation therapy using frontal technique with active breathing control in the treatment of gastric MALT lymphoma: implications for normal tissue sparing. Proceedings of the American Society of Radiation Oncology Annual Meeting. In Press.
5. Dabaja B, Voong R, Shihadeh F, Arzu I, Pinnix CC, Mazloom A, Medeiros L, Romaguera J, Rodriguez M, Allen P. Radiation therapy is a very effective modality in the treatment of mantle cell lymphoma, > 80% complete disappearance of disease site in heavily pretreated patients. Proceedings of the American Society of Radiation Oncology Annual Meeting. In Press.
6. Akhtari M, Reddy J, Pinnix C, Allen P, Osborne E, Gunther J, Milgrom S, Smith G, Wogan C, Fowler N, Rodriguez A, Dabaja B. Excellent Outcomes in Primary Cutaneous B-Cell Lymphoma after very Low Dose Radiation. ASTRO 57th Annual Meeting, 2015.
7. Milgrom S, Nieto Y, Pinnix C, Smith G, Reed V, Kebriaei P, Dabaja B. Graft-Versus-Host Disease Following Radiation Therapy in Patients with a History of Allogeneic Stem Cell Transplant. ASTRO 57th Annual Meeting,, 2015.
8. Pinnix C, Esmaeli B, Smith G, Milgrom S, Reed V, Arzu I, Shank J, Horace P, Allen K, Turner S, Morrell G, Fowler N, Dabaja B. Low dose 4 Gy Orbital Radiation for Therapy of Indolent B-Cell Lymphoma of the Ocular Adnexa. ASTRO 57th Annual Meeting, 2015.
9. Pinnix C, Smith G, Milgrom S, Osborne E, Reddy J , Akhtari M, Reed V, Arzu I, Allen P, Wogan C, Fanale M, Oki Y, Turturro F, Romaguera J, Fayad L, Fowler N, Westin J, Nastoupil L, Hagemeister F, Rodriguez A, Ahmed S, Nieto Y, Dabaja B. Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non Hodgkin Lymphoma. ASTRO 57th Annual Meeting, 2015.
10. Pinnix C, Dabaja B, Milgrom S, Smith G, Reed V, Arzu I, Westin J, Rondon G, Hosing C, Nieto Y, Ahmed S. Salvage Radiation Therapy Prior to Stem Cell Transplantation for Chemorefractory B-Cell Lymphoma. ASTRO 57th Annual Meeting, 2015.
11. Pinnix CC, Patel K, Reed V, Oki Y, Fayad L, Westin J, Turturro F, Romaguera J, Qazilbash M, Muzzafar T, Weber D, Fowler N, Popat U, Fanale M, Nieto Y, Shah N, Bashir Q, Hagemeister F, Orlowski R, Medeiros J, Dabaja B, Shah J. The outcome of limited stage plasmablastic lymphoma treated with and without radiation therapy: a single institutional experience. American Society of Radiation Oncology Annual Meeting, 2014.
12. Pinnix CC, Westin J, Ahmed MA, Reed V, Romaguera JE, Oki Y, Rodriguez MA, Fayad L, Hagemeister FB, Kwak LW, Medeiros LJ, Turturro F, Davis RE, Dabaja B. The role of radiation therapy in the treatment of primary mediastinal B cell lymphoma treated with rituximab containing regimens. American Society of Radiation Oncology Annual Meeting, 2014.
13. Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH. Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 81(2):S70 (#137), 2011.
14. Pinnix CC, Likhacheva A, Parikh N, Chiu M, Allen PK, Mahajan A, McAleer M, Sulman EP, Guha-Thakurta N, Chang E. Identification of clinical factors to help predict for early rapid MRI progression (ERMP) of brain metastasis patients undergoing gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 81(2):S644 (#2905), 2011.
15. Parikh N, Likhacheva A, Pinnix CC, Allen P, McAleer M, Chiu M, Sulman E, Mahajan A, Prabhu S, Chang E. Radiosurgery in patients with “radioresistant” brain metastases: outcomes and prognosis. Int J Radiat Oncol Biol Phys 81(2):S652 (#2922), 2011.
16. Pinnix CC, Skinner HD, Wang X, Zhang SX, Pan T, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward W, Chang JY, Buchholz TA, Yu TK. Assessing resting respiration-induced cardiac motion into the tangential treatment fields of breast cancer radiotherapy. Proceedings of the American Radium Society 92nd Annual Meeting, 2010.
17. Wang X, Pan T, Pinnix CC, Gladish G, Strom E, Perkins G, Tereffe W, Woodward W, Thomas B, Kuan TY. Assessing the displacement of left anterior descending artery (LAD) during cardiac motion for radiotherapy of breast cancer. Int J Radiat Oncol Biol Phys 78(3):S158 (#1041), 2010.
18. Mahajan A, Anderson P, McAleer M, Sulman E, Pinnix CC, Woo SY, Herzog C, Hayes-Jordan A. Multidisciplinary management with whole abdominal IMRT of desmoplastic small round cell tumor. Int J Radiat Oncol Biol Phys 78(3):S593 (#2871), 2010.
19. Pinnix CC, Arriaga L, Munsell MF, Kelly P, Perkins GH, Strom EA, Tereffe W, Woodward W, Oh JL, Buchholz TA, Yu TK. Randomized phase III clinical trial to compare topical hyaluronic acid-based and petrolatum-based gels for radiation dermatitis in breast cancer patients. Int J Radiat Oncol Biol Phys 78(3):S6 (#12), 2010.

Book Chapters

1. Pinnix CC, Dabaja BS. Leukemia including lymphoblastic lymphoma. In: Radiation Medicine Rounds: Hematologic Malignancies. 3(3). Ed(s) MB Tomblyn, KM Winkfield, BS Dabaja, CR Thomas. Demos Medical Publishing: New York, 459-470, 2012. ISBN: 9781936287772.
2. Pinnix CC, Dabaja BS. Marginal zone lymphoma. In: Radiation Medicine Rounds: Hematologic Malignancies. 3(3). Ed(s) MB Tomblyn, KM Winkfield, BS Dabaja, CR Thomas. Demos Medical Publishing: New York, 407-417, 2012. ISBN: 9781936287772.

Last updated: 8/19/2016